Ferritin Elevation and Improved Responsiveness to Erythropoiesis-Stimulating Agents in Patients on Ferric Citrate Hydrate.

about

Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients?Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide.

P2860

Q39440902-B1385F99-425B-4F52-B0C8-75ACFCD4AD60 Q55184664-2D4AC9E0-7A00-4B05-B4A1-D034653293C8

P2860

Ferritin Elevation and Improved Responsiveness to Erythropoiesis-Stimulating Agents in Patients on Ferric Citrate Hydrate.

Item

http://www.wikidata.org/entity/Q45853530

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ferritin Elevation and Improve ...... nts on Ferric Citrate Hydrate.

@en

Ferritin Elevation and Improve ...... nts on Ferric Citrate Hydrate.

@nl

type

Item

label

Ferritin Elevation and Improve ...... nts on Ferric Citrate Hydrate.

@en

Ferritin Elevation and Improve ...... nts on Ferric Citrate Hydrate.

@nl

prefLabel

Ferritin Elevation and Improve ...... nts on Ferric Citrate Hydrate.

@en

Ferritin Elevation and Improve ...... nts on Ferric Citrate Hydrate.

@nl

P1476

Ferritin Elevation and Improve ...... nts on Ferric Citrate Hydrate.

@en

P2093

Hideki Hirakata

http://www.w3.org/2001/XMLSchema#string

Kana Yamada

http://www.w3.org/2001/XMLSchema#string

Keitaro Yokoyama

http://www.w3.org/2001/XMLSchema#string

Masaaki Nakayama

http://www.w3.org/2001/XMLSchema#string

Steven Fishbane

http://www.w3.org/2001/XMLSchema#string

Takashi Akiba

http://www.w3.org/2001/XMLSchema#string

Toshiya Otoguro

http://www.w3.org/2001/XMLSchema#string

Yasuo Nagamine

http://www.w3.org/2001/XMLSchema#string

P2860

Considerations and challenges in defining optimal iron utilization in hemodialysis

Ferric citrate controls phosphorus and delivers iron in patients on dialysis.

No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.

The role of hepcidin, ferroportin, HCP1, and DMT1 protein in iron absorption in the human digestive tract.

Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Iron-hepcidin dysmetabolism, anemia and renal hypoxia, inflammation and fibrosis in the remnant kidney rat model.

Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing

Next-generation phosphate binders: focus on iron-based binders.

Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.

P304

359-365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EKIR.2016.12.005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Masafumi Fukagawa

P577

2017-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29142965

http://www.w3.org/2001/XMLSchema#string

P921

ferric citrate monohydrate

P932

5678664

http://www.w3.org/2001/XMLSchema#string

Ferritin Elevation and Improved Responsiveness to Erythropoiesis-Stimulating Agents in Patients on Ferric Citrate Hydrate.

about

P2860

P2860

Ferritin Elevation and Improved Responsiveness to Erythropoiesis-Stimulating Agents in Patients on Ferric Citrate Hydrate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932